Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products, today announced upcoming presentations at the ...

First quarter revenue of $1,152 million decreased 3% year-over-yearFirst quarter operating income of $123 million decreased 13% ...

The bland Tim Cook era is finally over at Apple, allowing the company to think differently again. I can't wait.

Discover how an average student, Mr. Sumit, transformed his preparation and cracked RBI Grade B. A real story of consistency, ...

Revenues for the first quarter of 2026 were $1,152 million, a decrease of 3% year-over-year and a decrease of 11% sequentially. Operating income in the first quarter of 2026 was $123 million, a ...

Pin design software allows users to create custom pins, including enamel designs, with various shapes, colors, and patterns. It helps artists, designers, and businesses produce print-ready designs ...

Designing molecules is one of chemistry's most complex challenges. From life-saving drugs to advanced materials, each ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

A new method developed at Baylor College of Medicine and collaborating institutions allows researchers to better understand ...

Security forces began enforcing entry restrictions on Dhul Qada 1, corresponding to April 19, as part of broader efforts to ...

Eli Lilly will acquire Kelonia Therapeutics for up to $7bn, securing its lentiviral-based in vivo CAR-T platform and oncology pipeline. The move follows Lilly’s $2.4bn purchase of Orna Therapeutics, ...

Galaxy A57 5G and A37 5G feature a sleek design, powerful triple camera and upgraded awesome intelligence to give users the ...